Profile
Michael Culler is the founder of Tiburio Therapeutics, Inc. He is currently the Director & Chief Scientific Officer at Amolyt Pharma SAS, a position held since 2018.
Michael Culler active positions
| Companies | Position | Start |
|---|---|---|
Amolyt Pharma SAS
Amolyt Pharma SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development in physical & natural sciences | Chief Tech/Sci/R&D Officer | 01/03/2018 |
Former positions of Michael Culler
| Companies | Position | End |
|---|---|---|
Tiburio Therapeutics, Inc.
Tiburio Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnological research and developmental services | Founder | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Amolyt Pharma SAS
Amolyt Pharma SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development in physical & natural sciences | Commercial Services |
Tiburio Therapeutics, Inc.
Tiburio Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnological research and developmental services | Health Technology |
- Stock Market
- Insiders
- Michael Culler
















